Table 1. Characteristics of 68 Patients with 88 HCCs.
| Characteristics | Value |
|---|---|
| Sex (male:female) | 55:13 |
| Age | |
| Men | 62.8 ± 9.8 (39–87) |
| Women | 64.7 ± 8.2 (52–82) |
| Tumor number per patient (%) | |
| n = 1 | 76.5 (52/68) |
| n = 2 | 20.6 (14/68) |
| n = 3 | 2.9 (2/68) |
| Presence of underlying liver disease (%) | |
| Chronic hepatitis B | 79.4 (54/68) |
| Chronic hepatitis C | 8.8 (6/68) |
| Alcoholic liver disease | 4.4 (3/68) |
| Non-B non-C liver cirrhosis | 5.9 (4/68) |
| Primary biliary cirrhosis | 1.5 (1/68) |
| Child-Pugh classification (%) | |
| Child-Pugh A | 95.6 (65/68) |
| Child-Pugh B | 4.4 (3/68) |
| History of local treatment (%) | |
| Yes | 45.6 (31/68) |
| RFA | 8.8 (6/68) |
| TACE | 22.1 (15/68) |
| PEI | 4.4 (3/68) |
| PEI and TACE | 5.9 (4/68) |
| RFA and TACE | 4.4 (3/68) |
| No | 54.4 (37/68) |
| Tumor size (cm) | |
| HCC (n = 88) | 1.6 ± 0.6 (0.6–3.2) |
| Tumor location (n = 88) | |
| Left lobe (%) | 26.1 (23/88) |
| S2:S2/3:S3:S4 | 6:2:6:9 |
| Right lobe (%) | 73.9 (65/88) |
| S5:S5/6:S6:S7:S8 | 8:4:17:12:24 |
| Tumor depth (%) | |
| Central | 51.1 (45/88) |
| Peripheral (within 10 mm from surface) | 48.9 (43/88) |
| Tumor level (%) | |
| Upper than portal hilum | 47.7 (42/88) |
| Hilar level | 15.9 (14/88) |
| Below portal hilum | 36.4 (32/88) |
| Nearby landmarks (%) | |
| Present | 34.1 (30/88) |
| Absent | 65.9 (58/88) |
| Locally progressed tumor after treatment* | |
| Yes (treatment-refractory tumor) (%) | 8.0 (7/88) |
| PEI:RFA:TACE | 2:1:4 |
| No (treatment-naïve tumor) (%) | 92.0 (81/88) |
Values are mean ± standard deviation (range). *Only for index tumors. HCC = hepatocellulcar carcinoma, PEI = percutaneous ethanol injection, RFA = radiofrequency ablation, TACE = transarterial chemoembolization